What Is a B-Type Natriuretic Peptide (BNP) Blood Test?

TLDR

A B-type natriuretic peptide, or BNP, blood test measures a peptide released in greater amounts when the heart is under increased pressure or strain. Clinicians commonly use it when evaluating symptoms that could involve heart failure, especially shortness of breath. It is a routine blood draw that generally requires no special preparation. A high value does not prove heart failure, and a low value does not exclude it in every person. BNP must be interpreted alongside symptoms, medical history, examination findings and, when needed, imaging or other tests.

If you are asking “what is b type natriuretic peptide blood test,” the short answer is that it is one piece of diagnostic evidence about how much stress the heart may be experiencing. It is not a stand-alone verdict about whether someone has heart failure.

What does a BNP blood test measure?

BNP is a signaling molecule made by the heart. It belongs to the broad group of biological messengers described in this plain-English guide to peptides. When pressure rises inside the heart or its walls are stretched, the heart generally releases more BNP into the bloodstream. Measuring its concentration can therefore provide indirect evidence of cardiac strain.

B-type natriuretic peptide is also sometimes called brain natriuretic peptide, an older name that can appear in medical records and research papers. Despite that name, the BNP measured for heart-failure assessment is closely associated with release from the heart.

The peptide participates in the body’s regulation of fluid, blood vessels and blood pressure. For diagnostic purposes, however, the key point is simpler: BNP tends to rise when the heart is working against increased pressure or volume. That biological relationship makes it useful as a biomarker—a measurable substance that provides information about a biological process.

Why would a clinician order the test?

A clinician may order BNP when symptoms could be caused by heart failure but could also have another explanation. These symptoms can include shortness of breath, reduced exercise tolerance, fatigue or swelling. None is specific to heart failure, so the test helps adjust the level of suspicion rather than replacing a full assessment.

This is especially relevant when someone presents with unexplained breathing difficulty. The 2022 AHA/ACC/HFSA heart-failure guideline describes BNP or NT-proBNP measurement as useful for supporting the diagnosis or exclusion of heart failure in people presenting with shortness of breath. The FDA has similarly described a BNP assay as an aid in diagnosing and assessing the severity of heart failure—not as an independent diagnostic test.

BNP has also been evaluated as a rapid test in emergency-department diagnostic studies. A systematic review of emergency and urgent-care evidence found that BNP and the related marker NT-proBNP were generally more useful for helping rule out acute heart failure than for conclusively confirming it. In practical terms, a lower result may reduce suspicion in an appropriate patient, while a higher result still requires an explanation.

What happens during a BNP test?

The test usually involves an ordinary blood sample drawn from a vein, often in the arm. No special preparation is generally required. Unless the clinician has ordered other blood tests with different instructions, fasting is usually unnecessary for BNP alone.

The collection process is brief. As with other routine blood draws, a person may feel a short sting and can occasionally develop minor bruising at the needle site. The laboratory then measures the BNP concentration and reports it with its own reference information.

The blood draw is simple, but interpretation is not. The reason for ordering the test, whether symptoms are new or chronic, the care setting and relevant health conditions can all affect what the number means.

How should BNP results be understood?

There is no single BNP value that can be treated as a universal dividing line between “healthy” and “heart failure.” Laboratories may use different assays, and clinical decision thresholds depend on the setting and purpose of testing. A value considered informative during an emergency evaluation may not answer the same question in an outpatient visit.

A responsible interpretation asks several questions:

Why was the test ordered, and what symptoms are present?
Was BNP measured, or was the related NT-proBNP test used?
Which assay and reference information did the laboratory use?
Is there kidney disease, an abnormal heart rhythm, lung disease or another condition that may affect the result?
Could age or body composition shift the expected concentration?
Do the examination, electrocardiogram, imaging and other findings point in the same direction?

This context explains why comparing a personal result with an isolated cutoff found online can be misleading. The number does not identify the cause of cardiac strain, and it cannot show by itself whether symptoms are due to heart failure.

What can cause a high BNP level?

Heart failure is an important cause of an elevated BNP level, but it is not the only one. BNP may also rise with kidney disease or kidney failure, atrial fibrillation, heart-valve disease, pulmonary embolism, pulmonary hypertension, severe pneumonia or sepsis. Concentrations also tend to be higher with older age.

These alternatives do not make an elevated result meaningless. They mean the result must be interpreted as evidence of possible cardiovascular strain within the person’s broader medical situation. For example, impaired kidney function can change how natriuretic-peptide concentrations behave, while serious lung or systemic illness can place additional stress on the heart.

A high BNP result therefore answers a limited question: it indicates that further clinical interpretation may be warranted. It does not independently identify heart failure, determine its cause or establish how it should be treated.

Can BNP be unexpectedly low?

Yes. Obesity is associated with lower BNP and NT-proBNP concentrations. As a result, a relatively low value may be less reliable for excluding heart failure in some people with obesity. This is one reason clinicians avoid interpreting BNP as a simple positive-or-negative test.

Timing and the person’s clinical presentation also matter. If symptoms and examination findings strongly suggest a heart or lung problem, an apparently reassuring biomarker value does not automatically end the evaluation. The test changes the probability of a diagnosis; it does not replace clinical judgment.

BNP and NT-proBNP are not the same test

BNP and NT-proBNP come from the same biological precursor, and both can provide evidence about cardiac pressure or strain. They are nevertheless different molecules with different behavior in the bloodstream. Their numerical values and decision thresholds are not interchangeable.

This distinction matters when reading results or comparing records. A BNP value should be interpreted using BNP-specific information from the laboratory and clinical setting. An NT-proBNP result requires NT-proBNP-specific interpretation. A cutoff quoted for one should never be casually applied to the other.

What may happen after an abnormal result?

The next step depends on why the test was ordered and what else the assessment shows. A clinician may review symptoms, medications, previous heart or kidney conditions, vital signs and examination findings. Other blood tests, an electrocardiogram, chest imaging or an echocardiogram may be considered.

An echocardiogram uses ultrasound to examine the heart’s structure and pumping function. It can provide information that BNP cannot, such as how the heart contracts, whether its chambers or valves appear abnormal, and whether certain pressures may be elevated. BNP can help determine whether further evaluation is appropriate, but imaging and clinical assessment are often needed to understand the reason for an abnormal result.

BNP or NT-proBNP may also be measured in people already known to have heart failure. However, the 2022 guideline found insufficient evidence to support using serial biomarker changes as a general strategy for directing heart-failure treatment. A changing result therefore should not be used to adjust treatment without the clinician responsible for that care.

When symptoms require urgent attention

A BNP test should not delay urgent assessment of severe or sudden breathing difficulty, chest pain or pressure, fainting, blue or gray lips, or rapidly worsening swelling. These symptoms can have multiple serious causes, and a person should not wait for a biomarker result or try to interpret an existing result before seeking emergency help.

Frequently asked questions

Do I need to fast before a BNP blood test?

Usually not. MedlinePlus states that no special preparation is generally needed for natriuretic-peptide testing. Follow the instructions provided for the full set of tests ordered, because another test collected at the same time may have separate requirements.

Does a high BNP result always mean heart failure?

No. Heart failure is one possible explanation, but kidney disease, atrial fibrillation, valve disease, pulmonary hypertension, pulmonary embolism, severe infection and other conditions can also raise BNP. Age can affect the expected concentration as well.

Can a normal BNP result rule out heart failure?

A low result can make acute heart failure less likely in the right clinical setting, and evidence suggests natriuretic peptides are particularly useful for this rule-out role. It is not an absolute guarantee. Obesity can suppress BNP levels, while the assay, symptoms and care setting also affect interpretation.

Is BNP a test for a heart attack?

BNP primarily provides information about pressure or strain affecting the heart; it is not the main biomarker used to diagnose a heart attack. Chest pain or pressure still requires prompt medical assessment regardless of a BNP result.

Can I compare my BNP with someone else’s NT-proBNP?

No. Although the tests reflect related biology, their values and clinical thresholds differ. Comparisons should use the exact marker, units, assay context and reference information reported by the laboratory.

The practical takeaway

A BNP blood test is a routine laboratory test that helps clinicians judge whether cardiac strain or heart failure may be contributing to symptoms. Its greatest value comes from combining it with the clinical picture. A high result is a reason to investigate, not proof of one diagnosis; a low result can be reassuring in some settings but is not infallible. The most useful next step is to review the exact test—BNP or NT-proBNP—with the clinician who knows why it was ordered and what the surrounding findings show.